Research Topics
| M MorrowSummaryAffiliation: Memorial Sloan-Kettering Cancer Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Trends in the surgical treatment of breast cancerMonica Morrow
Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
Breast J 16:S17-9. 2010..Further progress in the individualization of local therapy requires a move beyond the fixation on disease burden and the recognition that extent of local therapy should be tailored to tumor biology...- A prospective study of variability in mammographic density during the menstrual cycleMonica Morrow
Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
Breast Cancer Res Treat 121:565-74. 2010.... - Surgeon recommendations and receipt of mastectomy for treatment of breast cancerMonica Morrow
Breast Surgery Service, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA
JAMA 302:1551-6. 2009..There is concern that mastectomy is overused in the United States... - Breast conservation and negative margins: how much is enough?M Morrow
Breast Surgery Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
Breast 18:S84-6. 2009..The need for margins larger than tumor not touching ink (invasive cancer) and 2mm (DCIS) should be considered in the context of the multiple other factors known to impact upon LR... - MRI for breast cancer screening, diagnosis, and treatmentMonica Morrow
Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Lancet 378:1804-11. 2011..MRI is better than other methods of assessing the response to neoadjuvant chemotherapy, and is helpful in identifying the primary tumour in patients who present with axillary adenopathy... - Magnetic resonance imaging for screening, diagnosis, and eligibility for breast-conserving surgery: promises and pitfallsMonica Morrow
Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, Evelyn H Lauder Breast Center, 300 East 66th Street, New York, NY 10065, USA
Surg Oncol Clin N Am 19:475-92. 2010..This goal can only be accomplished through a multidisciplinary approach that examines the applications of newer diagnostic modalities such as MRI... 
Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancerKatherine E Posther
Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA
Ann Surg 242:593-9; discussion 599-602. 2005....- Predictors of completion axillary lymph node dissection in patients with immunohistochemical metastases to the sentinel lymph node in breast cancerMatthew S Pugliese
Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Ann Surg Oncol 17:1063-8. 2010..The goal of this study was to examine factors associated with ALND in IHC-only patients... 
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromesJose G Guillem
Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Room C 1077, New York, New York 10021, USA
Ann Surg Oncol 13:1296-321. 2006..Clinical interventions have been formulated for mutation carriers within affected families. The primary interventions for mutation carriers of highly penetrant syndromes are surgical...- ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromesJose G Guillem
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 24:4642-60. 2006.... - Predictors of completion axillary lymph node dissection in patients with positive sentinel lymph nodesAmer K Karam
Department of Surgery, Breast Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Ann Surg Oncol 16:1952-8. 2009..We sought to determine the sociodemographic, pathologic, and therapeutic variables that were associated with CALND... - Surgical management of the axilla: do intramammary nodes matter?Matthew S Pugliese
Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Am J Surg 198:532-7. 2009..The purpose of this study was to identify the appropriate surgical management of the axilla in intramammary node-positive patients undergoing sentinel lymph node (SLN) biopsy... - The clinical impact and outcomes of immunohistochemistry-only metastasis in breast cancerMatthew Pugliese
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Am J Surg 200:368-73. 2010..Modern surgical and pathological techniques can detect small-volume axillary metastases in breast cancer with unknown clinical significance... - What is an adequate margin for breast-conserving surgery? Surgeon attitudes and correlatesMichelle Azu
Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, USA
Ann Surg Oncol 17:558-63. 2010..A population-based surgeon sample was used to determine current attitudes toward margin width and identify characteristics associated with margin choice... - Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment?Elisa Rush Port
Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, Evelyn H Lauder Breast Center, New York, New York 10065, USA
Cancer 116:1987-91. 2010..They hypothesized that this variation is an unrecognized source of bias for studies examining the morbidity of SLN biopsy... - Is axillary dissection necessary after positive sentinel node biopsy? Yes!M Morrow
Lynn Sage Breast Center, Department of Surgery, Northwestern University, Chicago, Illinois, USA
Ann Surg Oncol 8:74S-76S. 2001..Until definitive data from the American College of Surgeons Z11 study is available, completion dissection should remain standard practice... - Understanding the impact of breast reconstruction on the surgical decision-making process for breast cancerAmy K Alderman
Department of Surgery, University of Michigan Medical Center, Ann Arbor, Michigan 48109 0340, USA
Cancer 112:489-94. 2008..Reconstruction is rarely incorporated into the decision-making process for surgical breast cancer treatment. We examined the importance of knowing about reconstruction to patients' surgical decision-making for breast cancer... - Presenting features of breast cancer differ by molecular subtypeLisa Wiechmann
Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Ann Surg Oncol 16:2705-10. 2009..Gene expression profiling of breast cancers identifies distinct molecular subtypes that affect prognosis. Our goal was to determine whether presenting features of tumors differ among molecular subtypes... - Current comprehensive assessment and management of women at increased risk for breast cancerAlan B Hollingsworth
Department of Surgery, Mercy Health Center, Mercy Women s Center, 4300 McAuley Blvd, Oklahoma City, OK 73120, USA
Am J Surg 187:349-62. 2004.... - Factors that influence surgical choices in women with breast carcinomaValerie L Staradub
Division of Surgical Oncology, Department of Surgery, Northwestern University Medical School, Chicago, Illinois, USA
Cancer 95:1185-90. 2002..The authors studied demographic factors to identify the variables that differed significantly among women making different surgical choices... - Breast cancerMonica Morrow
Department of Surgery, Northwestern University, Chicago, IL 60611, USA
BMJ 324:410-4. 2002 - A clinical oncologic perspective on breast magnetic resonance imagingSara Bloom
Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, Evelyn H Lauder Breast Center, 300 East 66th Street, New York, NY 10065, USA
Magn Reson Imaging Clin N Am 18:277-94, ix. 2010..In problem areas, such as evaluation of response to neoadjuvant therapy and detection of cancer presenting as axillary adenopathy, MR imaging provides information that is useful for clinical management... - Tamoxifen use in patients with ductal carcinoma in situ and T1a/b N0 invasive carcinomaFaina Nakhlis
Department of Surgery, Lynn Sage Breast Program, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
J Am Coll Surg 201:688-94. 2005..02) and accepting tamoxifen (p = 0.002) on univariate analysis. CONCLUSIONS: Factors associated with tamoxifen risks and benefits correlate poorly with the use of the drug... - Changes in breast cancer therapy because of pathology second opinionsValerie L Staradub
Department of Surgery, Northwestern University School of Medicine, Chicago, Illinois, USA
Ann Surg Oncol 9:982-7. 2002..The purpose of this study was to determine how often the pathologic second opinion (1) altered the diagnosis and (2) resulted in a change in the surgical procedure... - Evaluation and management of the woman with an abnormal ductal lavageMonica Morrow
Lynn Sage Breast Program, Department of Surgery, Northwestern University, Chicago, IL, USA
J Am Coll Surg 194:648-56. 2002 - Ductal lavage findings in women with known breast cancer undergoing mastectomySeema A Khan
Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago IL, USA
J Natl Cancer Inst 96:1510-7. 2004..To assess the utility of ductal lavage as a cancer diagnostic test, we investigated the association between ductal lavage cytologic findings and histologic findings in women with known breast cancer undergoing mastectomy... - Correlates of referral practices of general surgeons to plastic surgeons for mastectomy reconstructionAmy K Alderman
Section of Plastic Surgery, Department of Surgery, The University of Michigan Medical Center, Ann Arbor, Michigan 48109 0340, USA
Cancer 109:1715-20. 2007..In this study, the authors used data from a large physician survey to examine factors associated with general surgeons' propensity to refer breast cancer patients to plastic surgeons prior to mastectomy... - Does aggressive local therapy improve survival in metastatic breast cancer?Seema A Khan
Department of Surgery, Northwestern University Medical School, and the American College of Surgeons, Chicago, Ill 60611, USA
Surgery 132:620-6; discussion 626-7. 2002..Women with metastatic breast cancer and an intact primary tumor are currently treated with systemic therapy. Local therapy of the primary tumor is considered irrelevant to the outcome, and is recommended only for palliation of symptoms... - Factors influencing the use of breast reconstruction postmastectomy: a National Cancer Database studyM Morrow
Department of Surgery, Northwestern University Medical School, Chicago, IL, USA
J Am Coll Surg 192:1-8. 2001..Predictors of the use of reconstruction do not reflect contraindications to the procedure, and indicate the need for both physician and patient education... - Incidental breast lesions identified by 18F-fluorodeoxyglucose-positron emission tomographyAlice Chung
Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Ann Surg Oncol 17:2119-25. 2010..We describe our experience with breast incidentalomas in a large series of PET scans performed for patients without a known history of breast cancer... - Stage IV breast cancer in the era of targeted therapy: does surgery of the primary tumor matter?Heather B Neuman
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Cancer 116:1226-33. 2010..The objective of the current study was to identify subsets of patients who may benefit from primary tumor treatment and assess the frequency of local disease progression... - A predictive model for the development of hormone-responsive breast cancerSeema Rao Gorla
Department of Surgery, The Lynn Sage Breast Program, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
Ann Surg Oncol 12:48-56. 2005..CONCLUSIONS: Our findings, if prospectively validated, may help identify those who would obtain the greatest benefit from hormonal chemoprevention strategies for breast cancer risk reduction... - Factors influencing outcomes for breast conservation therapy of mammographically detected malignanciesValerie L Staradub
Lynn Sage Breast Center, Department of Surgery, Division of Surgical Oncology, Northwestern University Medical School, 201 E. Huron Street, Galter 10-105, Chicago, IL 60611, USA
J Am Coll Surg 196:518-24. 2003..In addition, surgeons with higher caseloads were better able to perform needle localization lumpectomy to negative margins while limiting the volume of normal breast tissue excised... - The effect of ipsilateral whole breast ultrasonography on the surgical management of breast carcinomaMehra Golshan
Department of Surgery, Lynn Sage Breast Center, Northwestern University, 251 East Huron St, Galter 13 174, Chicago, IL 60611, USA
Am J Surg 186:391-6. 2003..Whole breast ultrasonography has been shown to identify lesions not seen on mammography. This study sought to determine how often whole breast ultrasonography changes the surgical management of breast cancer... - Racial and ethnic disparities in the use of postmastectomy breast reconstruction: results from a population- based studyAmy K Alderman
Section of Plastic Surgery, Department of Surgery, University of Michigan Medical Center Ann Arbor, MI 48109 0340, USA
J Clin Oncol 27:5325-30. 2009..There is concern that minority women have limited access to breast reconstruction. We described patterns of use, experiences with clinicians, and patients' satisfaction with treatment decisions for women of different race/ethnicities... - Available models for breast cancer risk assessment: how accurate are they?Julia Tchou
Department of Surgery, Northwestern University Medical School, and the Lynn Sage Breast Program, Chicago, IL 60611, USA
J Am Coll Surg 197:1029-35. 2003 - A comparison of ductoscopy-guided and conventional surgical excision in women with spontaneous nipple dischargeRobyn M Moncrief
Department of Surgery, Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611, USA
Ann Surg 241:575-81. 2005..A prospective study is required to obtain an unbiased assessment of these possible advantages... - Patients with a history of epithelial ovarian cancer presenting with a breast and/or axillary massAmer K Karam
Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, MRI Suite 10 26, New York, NY 10065, USA
Gynecol Oncol 112:490-5. 2009..We sought to review our experience with patients with a history of EOC presenting with a breast and/or axillary mass to determine if clinical features differed between these entities... - Prediction of breast cancer size by ultrasound, mammography and core biopsyM Golshan
Department of Surgery, Lynn Sage Breast Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
Breast 13:265-71. 2004..The combination of the three modalities understaged 25% of the tumors > 1cm in size, and overstaged 10% of those < 1cm. The inability to accurately determine tumor size has important implications for the use of non-surgical ablation... - The evolution of the locoregional therapy of breast cancerAlice Ho
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
Oncologist 16:1367-79. 2011..The combination of the smaller cancers detected with screening and the routine use of multimodality therapy has resulted in a decrease in the morbidity of local therapy and improved cancer treatment outcomes... - alphaB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancerOlga Ivanov
Department of Surgery, Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA
Breast Cancer Res Treat 111:411-7. 2008..We examined whether alphaB-crystallin expression in breast cancer was associated with a poor response to neoadjuvant (preoperative) chemotherapy... - Randomized clinical trials in breast cancerAimee M Crago
Division of Surgical Oncology, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
Surg Oncol Clin N Am 19:33-58. 2010.... - Ductal carcinoma in situFaina Nakhlis
Department of Surgery, Feinberg School of Medicine of Northwestern University, 676 North St. Clair Street, Galter 13-174, Chicago, IL 61611, USA
Surg Clin North Am 83:821-39. 2003.... - A prospective evaluation of the durability of palliative interventions for patients with metastatic breast cancerMary Morrogh
Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center New York, New York 10065, USA
Cancer 116:3338-47. 2010..In this article, the authors report the frequency and durability of palliative procedures performed in the setting of MBC...